Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.920
-0.120 (-5.88%)
At close: Aug 8, 2025, 4:00 PM
1.930
+0.010 (0.52%)
After-hours: Aug 8, 2025, 7:59 PM EDT
Daré Bioscience Employees
As of December 31, 2024, Daré Bioscience had 23 total employees, including 21 full-time and 2 part-time employees. The number of employees decreased by 3 or -11.54% compared to the previous year.
Employees
23
Change (1Y)
-3
Growth (1Y)
-11.54%
Revenue / Employee
$1,126
Profits / Employee
-$72,893
Market Cap
16.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23 | -3 | -11.54% |
Dec 31, 2023 | 26 | -4 | -13.33% |
Dec 31, 2022 | 30 | 2 | 7.14% |
Dec 31, 2021 | 28 | 5 | 21.74% |
Dec 31, 2020 | 23 | 5 | 27.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DARE News
- 3 days ago - Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 - GlobeNewsWire
- 12 days ago - Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream - GlobeNewsWire
- 20 days ago - UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar - GlobeNewsWire
- 27 days ago - Crude Oil Moves Lower; Daré Bioscience Shares Jump - Benzinga
- 27 days ago - Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive - GlobeNewsWire
- 4 weeks ago - Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders - GlobeNewsWire
- 2 months ago - Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders - GlobeNewsWire
- 3 months ago - Daré Bioscience, Inc. (DARE) Q1 2025 Earnings Call Transcript - Seeking Alpha